Wednesday, August 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 27, 2026

Anthropic eyes an October IPO, which could raise over $60B

View original at finance.yahoo.com
Anthropic eyes an October IPO, which could raise over $60B Yahoo Finance Technology Editor Dan Howley joins Josh Lipton to break down reports that Anthropic (ANTH.PVT) could go public as soon as October, as it looks to get ahead of OpenAI (OPAI.PVT) in the intensifying AI race…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Anthropic wants to get ahead of OpenAI in the IPO race

    60% confidence

  • OpenAI has been paring down offerings to refocus

    60% confidence

  • Outside of Google and Microsoft, Anthropic IPO is one of the biggest ways to invest in AI model companies

    60% confidence

  • Revenue versus spending is better for Anthropic compared to OpenAI

    60% confidence

  • Anthropic could go public as soon as October and raise over $60 billion

    60% confidence

  • Anthropic is positioning itself as the more refined option for AI investors

    60% confidence

  • Investor risks for Anthropic include spending, competition, and regulation

    60% confidence

Data points we hold from this source

Anthropic · potential ipo valuation60 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
Anthropic eyes an October IPO, which could raise over $60B — Source | Via News | ViaNews Market